New Developments in Point-of-Care (POC) Diagnostics - Kalorama White Paper

New Developments in Point-of-Care (POC) Diagnostics - Kalorama White Paper

This post was adapted from a recently released Kalorama Information white paper on clinical point-of-care diagnostics. To receive the white paper, contact a customer service representative at 1-800-298-5603 (intl. +1 240 747 3096) or customerservice@kaloramainformation.com to register your company for free at www.kaloramainformation.com. For additional current and authoritative analysis of the POC diagnostics market, consult Kalorama Information’s market research reportThe World Market for Point of Care (POC) Diagnostics.

The expansion of molecular diagnostics into the domain of point-of-care (POC) or near-patient testing has rightfully drawn attention for its disruptive potential, though other promising technological fronts in POC diagnostics are also likely to drive future growth in the market. The IVD industry has widely recognized the directives indirectly and directly posed by the Affordable Care Act (ACA), accountable care initiatives, personalized medicine, and eHealth. Integrated into molecular POC and other advanced near-patient IVD, connectivity features, biosensors and microfluidics are also integrating such devices more holistically with patient care.

Microfluidics and biosensors have been fundamental to the development of molecular POC diagnostics, but are also part of other testing platforms. Biosensors use substrates, nanomaterials and advanced spectroscopic or electromagnetic wavelength analysis methods to perform extremely sensitive testing on a small platform that signals results through an electronic digital system. Biosensors can generate signals from results including chemiluminescence (clinical chemistry), fluorescence (molecular, immunodiagnostics), optical imaging (cytometry, blood typing, cardiac markers), and immunochromatography (immunodiagnostics). Small microfluidic channels are used to focus samples and analyte concentrations for more sensitive detection by biosensors. Together, these two technologies enable accurate and fast performance of traditionally lab-based IVD tests on a platform that can be hand-held or fit easily on a clinic counter.

In order for POC testing to deliver on greater healthcare goals of more routine preventative care, near-patient devices will require more effective communication of patient results among clinicians. Device connectivity is increasingly imperative, both in healthcare settings and even at home or with patient self-testing. Suppliers of POC testing products and third-party vendors have appropriately standardized POC instrument-desktop/laptop computer connectivity, complete with data management software or features, and have developed solutions for data conversion and availability on same-party and third-party information systems. Continued consolidation in healthcare systems and mounting pressure to coordinate care and eliminate unnecessary repeat services will encourage greater penetration of connectivity solutions among POC instruments and devices.

After registering with Kalorama Information, read the POC diagnostics white paper for more industry analysis including vendor and product examples of biosensors, microfluidics, and connectivity. Market segmentation and forecasts are available inThe World Market for Point of Care (POC) Diagnostics.